Patents Assigned to Shin Kong Wu Ho-Su Memorial Hospital
  • Patent number: 11135256
    Abstract: A pharmaceutical composition for ischemia treatment of a patient includes a ginkgo extraction and a pharmaceutically acceptable carrier. The dosage form of the pharmaceutical composition is gel, transdermal patch, cream or paste. The patient is a neonate, an infant, or an early child. A use of the pharmaceutical composition for ischemia treatment of a patient is disclosed.
    Type: Grant
    Filed: November 29, 2019
    Date of Patent: October 5, 2021
    Assignee: SHIN-KONG WU HO-SU MEMORIAL HOSPITAL
    Inventor: Shu-Chi Mu
  • Patent number: 8445456
    Abstract: A use of a nucleic acid molecule mediating RNA interference for treating or reducing pain is disclosed. The nucleic acid molecule has a sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3 and SEQ ID NO:4, and is used for effectively inhibiting expression of bradykinin B2 receptor, treating or reducing pain and preparing a pharmaceutical composition for reducing neuropathic pain.
    Type: Grant
    Filed: July 14, 2011
    Date of Patent: May 21, 2013
    Assignees: Fu-Jen Catholic University, Shin Kong Wu Ho Su Memorial Hospital
    Inventors: Ming-Dar Tsai, Yih-Jing Lee
  • Publication number: 20120289578
    Abstract: A use of a nucleic acid molecule mediating RNA interference for treating or reducing pain is disclosed. The nucleic acid molecule has a sequence selected from the group consisting of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3 and SEQ ID NO:4, and is used for effectively inhibiting expression of bradykinin B2 receptor, treating or reducing pain and preparing a pharmaceutical composition for reducing neuropathic pain.
    Type: Application
    Filed: July 14, 2011
    Publication date: November 15, 2012
    Applicants: SHIN KONG WU HO SU MEMORIAL HOSPITAL, FU-JEN CATHOLIC UNIVERSITY
    Inventors: Ming-Dar Tsai, Yih-Jing Lee
  • Patent number: 7807378
    Abstract: The present invention relates to methods of diagnosing myasthenia gravis in a subject, by determining an amount of at least one autoantibody that specifically binds one or more autoantigens selected from heat-shock protein 60 (hsp60), heat-shock protein 90, alpha isoform (hsp90?), and heat-shock protein 90, beta isoform (hsp90?). The invention also provides diagnostic kits for identifying a subject having myasthenia gravis.
    Type: Grant
    Filed: December 29, 2005
    Date of Patent: October 5, 2010
    Assignees: Industrial Technology Research Institute (ITRI), National Health Research Institutes (NHRI), Shin Kong Wu Ho-Su Memorial Hospital
    Inventors: Tzu-Ling Tseng, Pei-Hsiu Liao, Ping-Fu Cheng, Shih-Feng Tsai, Hou-Chang Chiu